669
Views
96
CrossRef citations to date
0
Altmetric
Review

Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis

, &
Pages 337-344 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Besufekad Mulugeta, Esubalew Tesfahun, Tadesse Mamo, Erzik Mohammaed, Ermiyas Endewent & Mollawork Ayele. (2023) Determinants of Community-Acquired Pneumonia Among Adults Patients Attending Debre Berhan University Hakim Gizaw Hospital, Northeast Ethiopia: A Case–Control Study. International Journal of General Medicine 16, pages 5271-5279.
Read now
James P Franciosi, Edward B Mougey, Evan S Dellon, Carolina Gutierrez-Junquera, Sonia Fernandez-Fernandez, Rajitha D Venkatesh & Sandeep K Gupta. (2022) Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions. Journal of Asthma and Allergy 15, pages 281-302.
Read now
Xiao-Yu Zhang, Tao Li, Haibing Wu, Yun Ling, Zhi-Ping Qian & Liang Chen. (2021) Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19. Journal of Inflammation Research 14, pages 287-298.
Read now
Zhuo Ma, Caixia Zhang, Xiangli Cui & Lihong Liu. (2019) Comparison of three criteria for potentially inappropriate medications in Chinese older adults. Clinical Interventions in Aging 14, pages 65-72.
Read now
Eline Houben, Saga Johansson, Péter Nagy, Fernie J. A. Penning-van Beest, Ernst J. Kuipers & Ron M. C. Herings. (2018) Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists. Current Medical Research and Opinion 34:4, pages 577-583.
Read now
Yvan Vandenplas & Bruno Hauser. (2015) An updated review on gastro-esophageal reflux in pediatrics. Expert Review of Gastroenterology & Hepatology 9:12, pages 1511-1521.
Read now
Robert MacLaren, Lynn E Kassel, Tyree H Kiser & Douglas N Fish. (2015) Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events. Expert Opinion on Drug Safety 14:2, pages 269-280.
Read now
Sheila M Wilhelm, Ryan G Rjater & Pramodini B Kale-Pradhan. (2013) Perils and pitfalls of long-term effects of proton pump inhibitors. Expert Review of Clinical Pharmacology 6:4, pages 443-451.
Read now
Tetsuhide Ito, Hisato Igarashi, Hirotsugu Uehara & Robert T Jensen. (2013) Pharmacotherapy of Zollinger–Ellison syndrome. Expert Opinion on Pharmacotherapy 14:3, pages 307-321.
Read now

Articles from other publishers (86)

Palittiya Sintusek, Mohamed Mutalib & Nikhil Thapar. (2023) Gastroesophageal reflux disease in children: What’s new right now?. World Journal of Gastrointestinal Endoscopy 15:3, pages 84-102.
Crossref
He Li, Li-li Li, Jian Wang, Yong-qiang Wang, Lan Wang, Lan Yuan, Wen-ting Chen & Jian-gang Song. (2022) Effect of electroacupuncture on the repair of stress ulcer injury in neurocritical patients: A randomized clinical trial. Frontiers in Medicine 9.
Crossref
Uwe Gröber. (2022) Protonenpumpenhemmer (PPI): Mikronährstoff-Räuber mit nachhaltigen Nebenwirkungen (Teil 1). Zeitschrift für Orthomolekulare Medizin 20:01, pages 14-21.
Crossref
Joseph Cusimano. (2022) Rabeprazole. WikiJournal of Medicine 9:1, pages 6.
Crossref
Philip O. Katz, Kerry B. Dunbar, Felice H. Schnoll-Sussman, Katarina B. Greer, Rena Yadlapati & Stuart Jon Spechler. (2022) ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology 117:1, pages 27-56.
Crossref
Oleksandr Khoma, Jin-soo Park, Felix Michael Lee, Hans Van der Wall & Gregory L. Falk. (2022) Different clinical symptom patterns in patients with reflux micro-aspiration. ERJ Open Research 8:1, pages 00508-2021.
Crossref
Yvan Vandenplas, Sébastien Kindt & Silvia Salvatore. 2022. Pediatric Neurogastroenterology. Pediatric Neurogastroenterology 439 456 .
Shishu Sharma & Mike Thomson. 2022. Gastroesophageal Reflux in Children. Gastroesophageal Reflux in Children 345 360 .
Anaïs Rameau, Katerina Andreadis, Ahmed Bayoumi, Matthew Kaufman & Peter Belafsky. (2021) Side Effects of Proton Pump Inhibitors: What are Patients’ Concerns?. Journal of Voice 35:5, pages 809.e15-809.e20.
Crossref
Marcus Fernando da Silva Praxedes, Gleideson Cerqueira dos Santos Pereira, Claudia Feio da Maia Lima, Djanilson Barbosa dos Santos & Jamille Sampaio Berhends. (2021) Prescrição de medicamentos potencialmente inapropriados para idosos segundo os Critérios de Beers: revisão sistemática. Ciência & Saúde Coletiva 26:8, pages 3209-3219.
Crossref
A. H. Morice, E. Millqvist, K. Bieksiene, S. S. Birring, P. Dicpinigaitis, Ch. D. RibasM. H. Boon, A. Kantar, K. Lai, L. McGarvey, D. Rigau, I. Satia, J. Smith, W.-J. Song, T. Tonia, J. W.K. Van den Berg, M. J.G. Van Manen & A. Zacharasiewicz. (2021) European Respiratory Society guidelines on the diagnosis and treatment of chronic cough in adults and children. PULMONOLOGIYA 31:4, pages 418-438.
Crossref
Shinako Miyano, Nobuaki Michihata, Ken-Ei Sada, Kazuaki Uda, Hiroki Matsui, Kiyohide Fushimi, Masaomi Nangaku & Hideo Yasunaga. (2021) Comparison of fracture risk between proton pump inhibitors and histamine-2 receptor antagonists in ANCA-associated vasculitis patients: a nested case–control study. Rheumatology 60:4, pages 1717-1723.
Crossref
Seung Won Lee, Eun Kyo Ha, Abdullah Özgür Yeniova, Sung Yong Moon, So Young Kim, Hyun Yong Koh, Jee Myung Yang, Su Jin Jeong, Sun Joon Moon, Joo Young Cho, In Kyung Yoo & Dong Keon Yon. (2021) Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching. Gut 70:1, pages 76-84.
Crossref
Yvan Vandenplas. 2021. Pediatric Gastrointestinal and Liver Disease. Pediatric Gastrointestinal and Liver Disease 212 229.e6 .
Jianyun Wu, Scott Dickinson, Zain Elgebaly, Suzanne Blogg, Aine Heaney, Yien Soo, Benjamin Daniels & Lynn Weekes. (2020) Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia. BMC Family Practice 21:1.
Crossref
Shino Kikuchi, Hissei Imai, Yoko Tani, Tomoko Tajiri & Norio Watanabe. (2020) Proton pump inhibitors for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2020:8.
Crossref
Friederike S. Luetzenberg & Nancy Jiang. (2019) Practice patterns of reflux medication prescriptions in otolaryngology compared to other specialties. The Laryngoscope 130:2, pages 321-327.
Crossref
Alyn H. Morice, Eva Millqvist, Kristina Bieksiene, Surinder S. Birring, Peter Dicpinigaitis, Christian Domingo Ribas, Michele Hilton Boon, Ahmad Kantar, Kefang Lai, Lorcan McGarvey, David Rigau, Imran Satia, Jacky Smith, Woo-Jung Song, Thomy Tonia, Jan W.K. van den Berg, Mirjam J.G. van Manen & Angela Zacharasiewicz. (2020) ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. European Respiratory Journal 55:1, pages 1901136.
Crossref
Charles Muller, Natalie Tapaskar & Robert T. Kavitt. 2020. Foregut Surgery. Foregut Surgery 121 143 .
Matthew H. Secrest, Robert W. Platt, Colin R. Dormuth, Dan Chateau, Laura Targownik, Rui Nie, Carla M. Doyle, Sophie Dell'Aniello & Kristian B. Filion. (2019) Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research. Pharmacoepidemiology and Drug Safety 29:S1, pages 26-34.
Crossref
Lama Soubra & Mohamed Issa. (2019) Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks. International Journal of Pharmacy Practice 27:4, pages 386-392.
Crossref
Woo-Jung Song, Ha-Kyeong Won, Jin An, Sung-Yoon Kang, Eun-Jung Jo, Yoon-Seok Chang, Byung-Jae Lee & Sang-Heon Cho. (2019) Chronic cough in the elderly. Pulmonary Pharmacology & Therapeutics 56, pages 63-68.
Crossref
Jingtao Chen & Patrick Brady. (2019) Gastroesophageal Reflux Disease. Gastroenterology Nursing 42:1, pages 20-28.
Crossref
Oliver J. Muensterer. 2019. Kinderchirurgie. Kinderchirurgie 351 373 .
Feng Li, Stephanie Denise Pointer & Jon P. Walker. 2019. The SAGES Manual of Foregut Surgery. The SAGES Manual of Foregut Surgery 147 160 .
Justin Field, Deena Midani, Yellowlees Douglas & Michael S. Smith. 2019. Laryngopharyngeal Reflux Disease. Laryngopharyngeal Reflux Disease 59 73 .
Ulrich Costabel, Jürgen Behr, Bruno Crestani, Wibke Stansen, Rozsa Schlenker-Herceg, Susanne Stowasser & Ganesh Raghu. (2018) Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials. Respiratory Research 19:1.
Crossref
Md.Mohaimenul Islam, Tahmina N. Poly, Bruno A. Walther, Navneet K. Dubey, Dina N. Anggraini Ningrum, Syed-Abdul Shabbir & Yu-Chuan (Jack) Li. (2018) Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 30:12, pages 1395-1405.
Crossref
Ha-Kyeong Won, Sol-Ji Yoon & Woo-Jung Song. (2018) The double-sidedness of cough in the elderly. Respiratory Physiology & Neurobiology 257, pages 65-69.
Crossref
Mark D. Wilkie, Helen M. Fraser & Hemal Raja. (2018) Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux. European Archives of Oto-Rhino-Laryngology 275:10, pages 2515-2521.
Crossref
Amandeep Singh, Gail A. Cresci & Donald F. Kirby. (2018) Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome. Nutrition in Clinical Practice 33:5, pages 614-624.
Crossref
Mei-Ling Blank, Lianne Parkin, Jiaxu Zeng & David Barson. (2018) Proton Pump Inhibitors and Infant Pneumonia/Other Lower Respiratory Tract Infections: National Nested Case-control Study. Journal of Pediatric Gastroenterology & Nutrition 67:3, pages 335-340.
Crossref
Shino Kikuchi, Yoko Naoki, Tomoko Tajiri & Norio Watanabe. (2018) Proton pump inhibitors for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews.
Crossref
Oleksandr Khoma, Susanna Elizabeth Falk, Leticia Burton, Hans Van der Wall & Gregory Leighton Falk. (2018) Gastro-Oesophageal Reflux and Aspiration: Does Laparoscopic Fundoplication Significantly Decrease Pulmonary Aspiration?. Lung 196:4, pages 491-496.
Crossref
Jan Zirk‐Sadowski, Jane A. Masoli, Joao Delgado, Willie Hamilton, W. David Strain, William Henley, David Melzer & Alessandro Ble. (2018) Proton‐Pump Inhibitors and Long‐Term Risk of Community‐Acquired Pneumonia in Older Adults. Journal of the American Geriatrics Society 66:7, pages 1332-1338.
Crossref
Daniel P. Demarque, Daniel R. Callejon, Gibson G. de Oliveira, Denise B. Silva, Carlos A. Carollo & Norberto P. Lopes. (2018) The role of tannins as antiulcer agents: a fluorescence-imaging based study. Revista Brasileira de Farmacognosia 28:4, pages 425-432.
Crossref
Giulia Gallusi & Stefano Pontone. (2018) Treatment of PPI-resistant gastro-oesophageal reflux: A systematic review. Arab Journal of Gastroenterology 19:2, pages 51-55.
Crossref
Valentina Guarnotta, Chiara Martini, Maria Vittoria Davì, Genoveffa Pizza, Annamaria Colao & Antongiulio Faggiano. (2017) The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?. Endocrine 60:1, pages 15-27.
Crossref
C A Batubara, K Ritarwan & A S Rambe. (2018) Effectiveness differences of ranitidine and omeprazole in prevention of stress ulcer and its effect on pneumonia occurrence and outcome of acute stroke patients. IOP Conference Series: Earth and Environmental Science 125, pages 012205.
Crossref
Sudha Pandit, Moheb Boktor, Jonathan S. Alexander, Felix Becker & James Morris. (2018) Gastroesophageal reflux disease: A clinical overview for primary care physicians. Pathophysiology 25:1, pages 1-11.
Crossref
M. Naunton, G. M. Peterson, L. S. Deeks, H. Young & S. Kosari. (2018) We have had a gutful: The need for deprescribing proton pump inhibitors. Journal of Clinical Pharmacy and Therapeutics 43:1, pages 65-72.
Crossref
Adis Medical Writers. (2017) Use acid-suppressing drugs appropriately with an individualized approach to minimize the risk of infection. Drugs & Therapy Perspectives 34:2, pages 67-72.
Crossref
Ines Held & Rhodri Pyart. (2018) Do stop me now: gastric acid-reducing drugs following renal transplantation. Journal of Kidney Care 3:1, pages 6-13.
Crossref
Amilcar M. Bigatao, Fernando A. M. Herbella, Leonardo M. Del Grande, Oliver A. Nascimento, Jose R. Jardim & Marco G. Patti. (2018) Chronic Obstructive Pulmonary Disease Exacerbations Are Influenced by Gastroesophageal Reflux Disease . The American Surgeon 84:1, pages 51-55.
Crossref
Waleed Alhazzani, Fayez Alshamsi, Emilie Belley-Cote, Diane Heels-Ansdell, Romina Brignardello-Petersen, Mustafa Alquraini, Anders Perner, Morten Hylander Møller, Mette Krag, Saleh Almenawer, Bram Rochwerg, Joanna Dionne, Roman Jaeschke, Mohammed Alshahrani, Adam Deane, Dan Perri, Lehana Thebane, Awad Al-Omari, Simon Finfer, Deborah Cook & Gordon Guyatt. (2017) Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Medicine 44:1, pages 1-11.
Crossref
Oliver J. Muensterer. 2018. Kinderchirurgie. Kinderchirurgie 1 23 .
Paul O. Lewis, Timothy S. Lundberg, Jennifer L. Tharp & Clay W. Runnels. (2017) Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics . Annals of Pharmacotherapy 51:10, pages 848-854.
Crossref
Chung-Han Ho, Yi-Chen Chen, Chin-Chen Chu, Jhi-Joung Wang & Kuang-Ming Liao. (2017) Age-adjusted Charlson comorbidity score is associated with the risk of empyema in patients with COPD. Medicine 96:36, pages e8040.
Crossref
Wan-Tseng Hsu, Chih-Cheng Lai, Ya-Hui Wang, Ping-Huei Tseng, Kun Wang, Cheng-Yi Wang & Likwang Chen. (2017) Risk of pneumonia in patients with gastroesophageal reflux disease: A population-based cohort study. PLOS ONE 12:8, pages e0183808.
Crossref
Kao-Chi Cheng, Kuan-Fu Liao, Cheng-Li Lin & Shih-Wei Lai. (2017) Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan. Frontiers in Pharmacology 8.
Crossref
Sai‐Wai Ho, Ying‐Hock Teng, Shun‐Fa Yang, Han‐Wei Yeh, Yu‐Hsun Wang, Ming‐Chih Chou & Chao‐Bin Yeh. (2017) Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients. Journal of the American Geriatrics Society 65:7, pages 1441-1447.
Crossref
Leon Fisher & Alexander Fisher. (2017) Acid-Suppressive Therapy and Risk of Infections: Pros and Cons. Clinical Drug Investigation 37:7, pages 587-624.
Crossref
Tatyana A. Shamliyan, Maria Middleton & Clarissa Borst. (2017) Patient-centered Outcomes with Concomitant Use of Proton Pump Inhibitors and Other Drugs. Clinical Therapeutics 39:2, pages 404-427.e36.
Crossref
Sung Soo KimYunju JoSeun Ja ParkJeong Seop MoonDong Ho LeeJae Jun KimYong Chan Lee. (2017) Risk of Bacterial Infection from Proton Pump Inhibitor Use. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 17:2, pages 79.
Crossref
Yunkai Dai, Yunzhan Zhang, Danyan Li, Jintong Ye, Weijing Chen & Ling Hu. (2017) Efficacy and Safety of Modified Banxia Xiexin Decoction (Pinellia Decoction for Draining the Heart) for Gastroesophageal Reflux Disease in Adults: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-17.
Crossref
Yvan Vandenplas. 2017. Pediatric Neurogastroenterology. Pediatric Neurogastroenterology 355 367 .
Jason Abramowitz, Punam Thakkar, Arton Isa, Alan Truong, Connie Park & Richard M. Rosenfeld. (2016) Adverse Event Reporting for Proton Pump Inhibitor Therapy. Otolaryngology–Head and Neck Surgery 155:4, pages 547-554.
Crossref
Katsuhiko Iwakiri, Yoshikazu Kinoshita, Yasuki Habu, Tadayuki Oshima, Noriaki Manabe, Yasuhiro Fujiwara, Akihito Nagahara, Osamu Kawamura, Ryuichi Iwakiri, Soji Ozawa, Kiyoshi Ashida, Shuichi Ohara, Hideyuki Kashiwagi, Kyoichi Adachi, Kazuhide Higuchi, Hiroto Miwa, Kazuma Fujimoto, Motoyasu Kusano, Yoshio Hoshihara, Tatsuyuki Kawano, Ken Haruma, Michio Hongo, Kentaro Sugano, Mamoru Watanabe & Tooru Shimosegawa. (2016) Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. Journal of Gastroenterology 51:8, pages 751-767.
Crossref
Joachim Mössner. (2016) The Indications, Applications, and Risks of Proton Pump Inhibitors. Deutsches Ärzteblatt international.
Crossref
Edward L. Jones, Michael P. Meara, Jennifer S. Schwartz, Jeffrey W. Hazey & Kyle A. Perry. (2015) Gastroesophageal reflux symptoms do not correlate with objective pH testing after peroral endoscopic myotomy. Surgical Endoscopy 30:3, pages 947-952.
Crossref
Lukas Buendgens. (2016) Prevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxis. World Journal of Critical Care Medicine 5:1, pages 57.
Crossref
Cristóbal de la Coba Ortiz, Federico Argüelles Arias, Carlos Martín de Argila de Prados, Javier Júdez Gutiérrez, Antonio Linares Rodríguez, Aida Ortega Alonso, Enrique Rodríguez de Santiago, Manuel Rodríguez-Téllez, María Isabel Vera Mendoza, Lara Aguilera Castro, Ángel Álvarez Sánchez, Raúl Jesús Andrade Bellido, Fidencio Bao Pérez, Manuel Castro Fernández & Froilán Giganto Tomé. (2016) Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva. Revista Española de Enfermedades Digestivas 108, pages 207-224.
Crossref
Gary J. Connett. (2016) Cystic Fibrosis Nutrition – Chewing the Fat. Paediatric Respiratory Reviews 17, pages 42-44.
Crossref
Yvan Vandenplas. 2016. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 105 130 .
Christopher V. Almario, David C. Metz, Kevin Haynes & Yu-Xiao Yang. (2015) Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia. European Journal of Gastroenterology & Hepatology 27:11, pages 1259-1264.
Crossref
M. Falguera & M.F. Ramírez. (2015) Community-acquired pneumonia. Revista Clínica Española (English Edition) 215:8, pages 458-467.
Crossref
M. Falguera & M.F. Ramírez. (2015) Neumonía adquirida en la comunidad. Revista Clínica Española 215:8, pages 458-467.
Crossref
Gary J. Connett & Katharine C. Pike. (2015) Nutritional outcomes in cystic fibrosis – are we doing enough?. Paediatric Respiratory Reviews 16, pages 31-34.
Crossref
L. Estborn & S. Joelson. (2015) Frequency and time to onset of community-acquired respiratory tract infections in patients receiving esomeprazole: a retrospective analysis of patient-level data in placebo-controlled studies. Alimentary Pharmacology & Therapeutics 42:5, pages 607-613.
Crossref
Allison A. Lambert, Jennifer O. Lam, Julie J. Paik, Cesar Ugarte-Gil, M. Bradley Drummond & Trevor A. Crowell. (2015) Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis. PLOS ONE 10:6, pages e0128004.
Crossref
P. S. Nishtala & L. Soo. (2015) Proton pump inhibitors utilisation in older people in New Zealand from 2005 to 2013. Internal Medicine Journal 45:6, pages 624-629.
Crossref
Marc Bardou, Jean-Pierre Quenot & Alan Barkun. (2015) Stress-related mucosal disease in the critically ill patient. Nature Reviews Gastroenterology & Hepatology 12:2, pages 98-107.
Crossref
Mitsuhiro Fujishiro, Kazuhide Higuchi, Mototsugu Kato, Yoshikazu Kinoshita, Ryuichi Iwakiri, Toshio Watanabe, Toshihisa Takeuchi, Nobuyuki SugisakiYasushi Okada, Hisao Ogawa, Tetsuo Arakawa & Kazuma Fujimoto. (2015) Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trial. Journal of Clinical Biochemistry and Nutrition 56:3, pages 228-239.
Crossref
C. Daniel Smith. 2015. Antireflux Surgery. Antireflux Surgery 205 218 .
Sunitha Kanchi Kandadai & Mark V. Boswell. 2015. Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care 345 363 .
Roser Vallès Fernández, Alícia Franzi Sisó & Juan José Ferro Rivera. (2014) Condiciones clínicas y terapéuticas que requieren gastroprotección. FMC - Formación Médica Continuada en Atención Primaria 21:9, pages 528-533.
Crossref
Carlos Alves, Francisco Batel Marques & Ana Filipa Macedo. (2014) Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting risks earlier. European Journal of Clinical Pharmacology 70:6, pages 745-756.
Crossref
Moe Htet Kyaw & Francis Ka Leung Chan. (2014) Pharmacologic Options in the Management of Upper Gastrointestinal Bleeding: Focus on the Elderly. Drugs & Aging 31:5, pages 349-361.
Crossref
Wanda P. Blanton & M. Michael Wolfe. 2014. Pocket Guide to Gastrointestinal Drugs. Pocket Guide to Gastrointestinal Drugs 15 30 .
Yvan Vandenplas. (2013) Management of paediatric GERD. Nature Reviews Gastroenterology & Hepatology 11:3, pages 147-157.
Crossref
Corrado Blandizzi & Carmelo Scarpignato. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 539 560 .
Alessandro Morandi, Giuseppe Bellelli, Eduard E. Vasilevskis, Renato Turco, Fabio Guerini, Tiziana Torpilliesi, Salvatore Speciale, Valeria Emiliani, Simona Gentile, John Schnelle & Marco Trabucchi. (2013) Predictors of Rehospitalization Among Elderly Patients Admitted to a Rehabilitation Hospital: The Role of Polypharmacy, Functional Status, and Length of Stay. Journal of the American Medical Directors Association 14:10, pages 761-767.
Crossref
Matthew A. Rysavy, Eric Ammann & Ryan Carnahan. (2013) Community-Acquired Pneumonia and Proton Pump Inhibitors. Journal of General Internal Medicine 28:7, pages 872-872.
Crossref
K. Pilarczyk, H. Carstens, D.-S. Dohle, G. Marggraf & H.G. Jakob. (2013) Rolle des Gastrointestinaltrakts im Rahmen kardiochirurgischer EingriffeRole of the gastrointestinal tract during cardiac surgery. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie 27:3, pages 193-205.
Crossref
David A. Johnson & Edward C. OldfieldIVIV. (2013) Reported Side Effects and Complications of Long-term Proton Pump Inhibitor Use: Dissecting the Evidence. Clinical Gastroenterology and Hepatology 11:5, pages 458-464.
Crossref
Philip O Katz, Lauren B Gerson & Marcelo F Vela. (2013) Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology 108:3, pages 308-328.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.